TOUYUN BIOTECH (01332) Shareholder Transfers Shares from Wutong Securities to KGI Asia, Portfolio Valued at HK$35.35 Million
Stock News
Jan 21
Latest data from the Hong Kong Stock Exchange reveals that on January 20, a shareholder of TOUYUN BIOTECH (01332) transferred shares from Wutong Securities to KGI Asia. The transferred portfolio was valued at HK$35.35 million, representing 5.04% of the company's shares.
TOUYUN BIOTECH previously announced its interim results for the six months ended June 30, 2025. The group reported revenue of HK$36.581 million from sales of goods and services provided, a decrease of 20.82% compared to the same period last year. Profit attributable to the company's owners was HK$11.243 million, a significant turnaround from a loss of HK$47.969 million in the prior year period. Earnings per share stood at 0.4 HK cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.